Closed System Solutions for Cell and Gene Therapy Manufacturing

Cell therapies offer a promising approach to treat severe and rare diseases. However, sustained manufacturing of cell therapy products is at risk due to the high costs associated with manufacturing variability and safety assessments. One significant risk in the manufacturing process is contamination of product, which can contribute to millions of dollars in added cost. In this webinar, we will address how integrating closed system approaches during process development or manufacturing can mitigate contamination risk and associated costs. This webinar will introduce viewers to Corning’s closed system solutions, with attention to the following topics: Assembly and customization of closed systems Closed system process considerations and flexibility in design Scaling up and out using closed systems Attend this webinar to learn more about: Benefits of closed systems Assessing risk of contamination Key considerations for closed system design